Explore
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
In the media
Owkin is named one of the top 10 most-funded AI healthcare startups
August 15, 2022
Owkin is named one of the top 10 most-funded AI healthcare startups
August 15, 2022
Becker's Hospital Review
In the media
How data-driven approaches to covariate adjustment help de-risk and accelerate clinical trials
July 22, 2022
How data-driven approaches to covariate adjustment help de-risk and accelerate clinical trials
July 22, 2022
Biocentury
In the media
AI Biotech unicorn Owkin is one step closer to using AI to boost drug discovery
July 20, 2022
AI Biotech unicorn Owkin is one step closer to using AI to boost drug discovery
July 20, 2022
Euronews.Next
Press release
Owkin, the Francis Crick Institute and The Royal Marsden NHS Foundation Trust partner to use AI for kidney cancer evolution
June 21, 2022
Owkin, the Francis Crick Institute and The Royal Marsden NHS Foundation Trust partner to use AI for kidney cancer evolution
June 21, 2022
Press release
Owkin and CancerLinQ use federated learning on real world oncology data to study lung cancer treatment
June 21, 2022
Owkin and CancerLinQ use federated learning on real world oncology data to study lung cancer treatment
June 21, 2022
Press release
Owkin welcomes political advisor Yedidia Levy-Zauberman as SVP of Public Affairs & Impact
June 21, 2022
Owkin welcomes political advisor Yedidia Levy-Zauberman as SVP of Public Affairs & Impact
June 21, 2022
Press release
Owkin partners with Arkhn and Inria to launch €10M OncoLab to standardize health data access
June 20, 2022
Owkin partners with Arkhn and Inria to launch €10M OncoLab to standardize health data access
June 20, 2022
In the media
Owkin and Arkhn join forces with Inria to make oncology data accessible
June 20, 2022
Owkin and Arkhn join forces with Inria to make oncology data accessible
June 20, 2022
L'Usine Digitale
In the media
Pharmaceutical giant Bristol Myers Squibb invests $80 million in Owkin to advance drug trials
June 8, 2022
Pharmaceutical giant Bristol Myers Squibb invests $80 million in Owkin to advance drug trials
June 8, 2022
Business Insider
Press release
Owkin announces multi-year clinical data science strategic collaboration with Bristol Myers Squibb
June 7, 2022
Owkin announces multi-year clinical data science strategic collaboration with Bristol Myers Squibb
June 7, 2022